Defining neuropathic pain

Anesthesia and Analgesia

Volumn 97, Issue 3, 2003, Pages 785-790

  Backonja, Misha Miroslav ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ANTINOCICEPTION; CLINICAL PRACTICE; CLINICAL RESEARCH; COMPARATIVE STUDY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; INFLAMMATION; MUSCLE WEAKNESS; NEUROLOGIC DISEASE; NEUROPATHIC PAIN; NOMENCLATURE; PAIN; PARESTHESIA; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING;

EID: 0041876261     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000062826.70846.8D     Document Type: Review

References (32)

1. Merskey H, Bogduk N. Classification of chronic pain. Seattle: IASP Press, 1994.
2. Bridges D, Thompson SW, Rice AS. Mechanisms of neuropathic pain. Br J Anaesth 2001;87:12-26.
3. McQuay HJ, Moore RA, Eccleston C, et al. Systematic review of outpatient services for chronic pain control. Health Technol Assess 2001;1:i-iv.
4. Portenoy RK. Current pharmacotherapy of chronic pain. J Pain Symptom Manage 2000;19:S16-20.
5. Saberski L. Pain generators 2002. The Pain Clinic 2002;4(3):32-5.
6. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science 2000;288:1765-9.
7. Ossipov MH, Lai J, Malan TP Jr, Porreca F. Spinal and supraspinal mechanisms of neuropathic pain. Ann N Y Acad Sci 2000;909:12-24.
8. Gracely RH, Lynch SA, Bennett GJ. Painful neuropathy: altered central processing maintained dynamically by peripheral input. Pain 1992;51:175-94.
9. Eide PK, Jorum E, Stubhaug A, et al. Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo. Pain 1994;58:347-54.
10. Rowbotham MC, Fields HL. The relationship of pain, allodynia and thermal sensation in post-herpetic neuralgia. Brain 1996;119:347-54.
11. Pappagallo M, Oaklander AL, Quatrano-Piacentini AL, et al. Heterogenous patterns of sensory dysfunction in postherpetic neuralgia suggest multiple pathophysiologic mechanisms. Anesthesiology 2000;92:691-8.
12. Kidd BL, Urban LA. Mechanisms of inflammatory pain. Br J Anaesth 2001;87:3-11.
13. Mitchell SW, Morehouse G, Keen W. Gunshot wounds, and other injuries of nerves. Philadelphia: Lippincott, 1864.
14. Dejerine JRG. La syndrome thalamique. Rev Neurol Fasc 1906;12:521-32.
15. Lindblom U, Ochoa J. Somatosensory function and dysfunction. In: Asbury AK, McKhann GM, McDonald WI, eds. Diseases of the nervous system: clinical neurobiology. Philadelphia: WB Saunders Co, 1986:283-98.
16. Hansson P, Lindblom U, Lindstrom P. Graded assessment and classification of impaired temperature sensibility in patients with diabetic polyneuropathy. J Neurol Neurosurg Psychiatry 1991;54:527-30.
17. Backonja MM, Galer BS. Pain assessment and evaluation of patients who have neuropathic pain. Neurol Clin 1998;16:775-90.
18. Janig W, Levine JD, Michaelis M. Interactions of sympathetic and primary afferent neurons following nerve injury and tissue trauma. Prog Brain Res 1996;113:161-84.
19. Weber M, Birklein F, Neundorfer B, Schmelz M. Facilitated neurogenic inflammation in complex regional pain syndrome. Pain 2001;91:251-7.
20. Veldman PH, Reynen HM, Arntz IE, Goris RJ. Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients. Lancet 1993;342:1012-6.
21. Sack K, Fey KH. Rheumatic diseases. In: Parslow TG, Stites DP, Terr AI, Imboden JB, eds. Medical immunology. New York: Lange Medical Books/McGraw-Hill Medical, 2001.
22. Dyck PJ, Dyck PJ, Larson TS, et al. Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: a study of three cohorts - nerve growth factor study group. Diabetes Care 2000;23:510-7.
23. Bogousslavsky J, Regli F, Uske A. Thalamic infarcts: clinical syndromes, etiology, and prognosis. Neurology 1988;38:837-48.
24. Hargreaves K, Dubner R, Brown F, et al. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988;32:77-88.
25. Rainville P, Feine JS, Bushnell MC, Duncan GH. A psychophysical comparison of sensory and affective responses to four modalities of experimental pain. Somatosens Motor Res 1992;9:265-77.
26. Taylor BK. Pathophysiologic mechanisms of neuropathic pain. Curr Pain Headache Rep 2001;5:151-61.
27. DeLeo JA, Yezierski RP. The role of neuroinflammation and neuroimmune activation in persistent pain. Pain 2001;90:1-6.
28. Colburn RW, Rickman AJ, DeLeo JA. The effect of site and type of nerve injury on spinal glial activation and neuropathic pain behavior. Exp Neurol 1999;157:289-304.
29. Watkins LR, Martin D, Ulrich P, et al. Evidence for the involvement of spinal cord glia in subcutaneous formalin induced hyperalgesia in the rat. Pain 1997;71:225-35.
30. Watkins LR, Milligan ED, Maier SF. Glial activation: a driving force for pathological pain. Trends Neurosci 2001;24:450-5.
31. Birklein F, Schmelz M, Schifter S, Weber M. The important role of neuropeptides in complex regional pain syndrome. Neurology 2001;57:2179-84.
32. Fallahati DM, Backonja M, Eghbalnia H, Assadi AH. Dynamic PCA for network feature extraction in multi-electrode recording of neurophysiological data in cortical substrate of pain. Neurocomputing 2002;46:401-5.